Showing results (1-10 of 39) with videos related to
Sort By:
Pageof 4
Journal of Parkinson'S Disease|October 15, 2019
The Appendix in Parkinson's Disease: From Vestigial Remnant to Vital Organ?Bryan Killinger, Viviane LabrieJournal of Innate Immunity|September 4, 2017
Alpha-Synuclein to the Rescue: Immune Cell Recruitment by Alpha-Synuclein during Gastrointestinal InfectionViviane Labrie, Patrik BrundinNeuroscience and Biobehavioral Reviews|August 22, 2009
The involvement of the NMDA receptor D-serine/glycine site in the pathophysiology and treatment of schizophreniaViviane Labrie, John C RoderNPJ Parkinson'S Disease|November 30, 2017
Vertebrate food products as a potential source of prion-like α-synucleinBryan Andrew Killinger, Viviane LabrieJournal of Parkinson'S Disease|October 30, 2016
Epigenetic Biomarkers for Parkinson's Disease: From Diagnostics to TherapeuticsJennifer L Jakubowski, Viviane LabrieTrends in Genetics : TIG|May 25, 2012
Epigenetics of major psychosis: progress, problems and perspectivesViviane Labrie, Shraddha Pai, Arturas PetronisNeuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|July 13, 2007
D-serine augments NMDA-NR2B receptor-dependent hippocampal long-term depression and spatial reversal learningSteven Duffy, Viviane Labrie, John C RoderPsychopharmacology|July 4, 2008
Mice with reduced NMDA receptor glycine affinity model some of the negative and cognitive symptoms of schizophreniaViviane Labrie, Tatiana Lipina, John C RoderPsychopharmacology|March 11, 2005
Modulators of the glycine site on NMDA receptors, D-serine and ALX 5407, display similar beneficial effects to clozapine in mouse models of schizophreniaTatiana Lipina, Viviane Labrie, Ina Weiner, et al.Pharmacology, Biochemistry, and Behavior|October 23, 2008
Mutant mice with reduced NMDA-NR1 glycine affinity or lack of D-amino acid oxidase function exhibit altered anxiety-like behaviorsViviane Labrie, Steven J Clapcote, John C RoderPageof 4